Expression Analysis Expands Advisory Board
Posted August 25, 2006
DURHAM, N.C. — Expression Analysis
, a provider of microarray testing, analysis and data management, is expanding its scientific advisory board.
New members include: John Ryan, chief medical officer of AVEO Pharmaceuticals; Richard Bockett, director of genomic medicine at Elil Lilly; and Buzz Sztukowski, senior vice president for global marketing and strategic development at bioMerieux.
"Our current Scientific Advisory Board members are thought leaders in genomic technologies and genomic medicine," said Steve McPhail, chief executive officer of Expression Analysis. "We believe that the new makeup of our Scientific Advisory Board will assist our company in our vision of bridging the use of microarray-based pharmacogenomic assays in clinical trials to targeted molecular diagnostics."